Wound Care Biologics Market Report 2021

Home   /   Wound Care Biologics Market Report 2021

Published Date: March 2022 | Pages: 127 | Category: Pharma and Healthcare | Report Code: GRMI23979

Extract:

 

Based on this comprehensive report published by Gravitas Market Insights, the Wound Care Biologics market is said to witness a significant growth during the forecast years between 2021 and 2028. Wound care biologics refer to the branch of drugs semi-synthesized or extracted from sources that are natural, especially the ones used for healing infections. Wound healing is an intricate procedure that involves accumulation of fibrous tissue, inflammation, deposition of collagen and various other disruptions.

 

Report Scope in detail:

This latest report edition of Wound Care Biologics market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Wound Care Biologics market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.

 

Market Dynamics:

  • Increasing prevalence of burn injuries particularly in underdeveloped and developing countries is predicted to promote the growth of wound care biologics market during the forecast period.
  • Increasing geriatric population is also one of the key factors responsible for the growth of this market.
  • Regionally, North America will lead the global wound care biologics market owing to the constant innovations in this industry. Furthermore, there are several government initiatives pertaining to wound care treatment in North America and Europe.
  • Besides, lack of trained physicians in underdeveloped economies coupled with higher cost of wound treatment will hinder the market growth during the forecast period.

 

Wound Care Biologics Market Segmentation:

 

By Type

  • Biological Skin Substitutes
  • Topical Agents

 

By Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Other Ulcers
  • Burns
  • Surgical and Traumatic Wounds

 

By End-Use

  • Ambulatory Surgical Centers
  • Hospitals/Clinics
  • Other End Users

 

Regional Coverage

 

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Competitive Analysis:

Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.

 

Few of the Key Players Covered in Our Report:

 

  • Integra LifeSciences Corporation
  • ACell Inc.
  • Marine Polymer Technologies Inc.
  • Kerecis
  • MISONIX Inc.
  • MiMedx Inc.
  • Smith & Nephew PLC
  • Molnlycke Health Care
  • Wright Medical Group NV
  • Solsys Medical
  • Vericel
  • Organogenesis

 

Impact of COVID19:

 

The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.

This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.



Market Estimation

Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.



Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.

Section 1: Executive Summary


1.1. Wound Care Biologics Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. Wound Type/Wound Type Trends
1.5. Regional Trends


Section 2: Market Dynamics - Wound Care Biologics Market Industry Insights


2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment


Section 3: Global Wound Care Biologics Market, By Type 


3.1. Segmentation Analysis, By Type, 2016-2028
3.2. Market Share Segmentation Analysis, By Type, 2016-2028
3.3. Biological Skin Substitutes
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.4. Topical Agents
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


Section 4: Global Wound Care Biologics Market, By Wound Type


4.1. Segmentation Analysis, By Wound Type, 2016-2028
4.2. Market Share Segmentation Analysis, By Wound Type, 2016-2028
4.3. Diabetic Foot Ulcers
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.4. Pressure Ulcers
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.5. Venous Ulcers
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.6. Other Ulcers
4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.7. Burns
4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.8. Surgical and Traumatic Wounds
4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


Section 5: Global Wound Care Biologics Market, By End-Use


5.1. Segmentation Analysis, By End-Use, 2016-2028
5.2. Market Share Segmentation Analysis, By End-Use, 2016-2028
5.3. Ambulatory Surgical Centers
5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4. Hospitals/Clinics
5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5. Other End Users
5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


Section 6: Global Wound Care Biologics Market, Regional Analysis


6.1. Global Wound Care Biologics Market, Regional Analysis
6.2. Global Wound Care Biologics Market Share, Regional Analysis


6.3. North America, Country level Analysis
6.3.1. North America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
6.3.2. North America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Wound Type, 2016 – 2028
6.3.3. North America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By End-Use, 2016 – 2028
6.3.4. United States
6.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.3.5. Canada
6.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.3.6. Mexico
6.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


6.4. Europe Country level Analysis
6.4.1. Europe Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
6.4.2. Europe Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Wound Type, 2016 – 2028
6.4.3. Europe Wound Care Biologics Market estimates and forecast with Growth rate analysis, By End-Use, 2016 – 2028
6.4.4. UK
6.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.5. Germany
6.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.6. France
6.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.7. Italy
6.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.8. Spain
6.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.9. Russia
6.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4.10. Rest of Europe
6.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


6.5. Asia-Pacific Country level Analysis
6.5.1. Asia-Pacific Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
6.5.2. Asia-Pacific Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Wound Type, 2016 – 2028
6.5.3. Asia-Pacific Wound Care Biologics Market estimates and forecast with Growth rate analysis, By End-Use, 2016 – 2028
6.5.4. China
6.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.5. India
6.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.6. Japan
6.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.7. Korea
6.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.8. Australia
6.5.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.9. Southeast Asia
6.5.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5.10. Rest of Asia-Pacific
6.5.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


6.6. South America Country level Analysis
6.6.1. South America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
6.6.2. South America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Wound Type, 2016 – 2028
6.6.3. South America Wound Care Biologics Market estimates and forecast with Growth rate analysis, By End-Use, 2016 – 2028
6.6.4. Brazil
6.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.6.5. Argentina
6.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.6.6. Colombia
6.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.6.7. Rest of South America
6.6.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028


6.7. Middle East & Africa Country level Analysis
6.7.1. MEA Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
6.7.2. MEA Wound Care Biologics Market estimates and forecast with Growth rate analysis, By Wound Type, 2016 – 2028
6.7.3. MEA Wound Care Biologics Market estimates and forecast with Growth rate analysis, By End-Use, 2016 – 2028
6.7.4. GCC
6.7.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.7.5. South Africa
6.7.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.7.6. Rest of Middle East & Africa
6.7.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028

 

Section 7: Company Profile - Wound Care Biologics Market


7.1. Integra LifeSciences Corporation
7.1.1. Business Overview
7.1.2. Product & Service Offering
7.1.3. Overall Revenue
7.1.4. Strategic Outlook


7.2. ACell Inc.
7.2.1. Business Overview
7.2.2. Product & Service Offering
7.2.3. Overall Revenue
7.2.4. Strategic Outlook


7.3. Marine Polymer Technologies Inc.
7.3.1. Business Overview
7.3.2. Product & Service Offering
7.3.3. Overall Revenue
7.3.4. Strategic Outlook


7.4. Kerecis
7.4.1. Business Overview
7.4.2. Product & Service Offering
7.4.3. Overall Revenue
7.4.4. Strategic Outlook


7.5. MISONIX Inc.
7.5.1. Business Overview
7.5.2. Product & Service Offering
7.5.3. Overall Revenue
7.5.4. Strategic Outlook


7.6. MiMedx Inc.
7.6.1. Business Overview
7.6.2. Product & Service Offering
7.6.3. Overall Revenue
7.6.4. Strategic Outlook


7.7. Smith & Nephew PLC
7.7.1. Business Overview
7.7.2. Product & Service Offering
7.7.3. Overall Revenue
7.7.4. Strategic Outlook


7.8. Molnlycke Health Care
7.8.1. Business Overview
7.8.2. Product & Service Offering
7.8.3. Overall Revenue
7.8.4. Strategic Outlook


7.9. Wright Medical Group NV
7.9.1. Business Overview
7.9.2. Product & Service Offering
7.9.3. Overall Revenue
7.9.4. Strategic Outlook


7.10. Solsys Medical
7.10.1. Business Overview
7.10.2. Product & Service Offering
7.10.3. Overall Revenue
7.10.4. Strategic Outlook


7.11. Vericel
7.11.1. Business Overview
7.11.2. Product & Service Offering
7.11.3. Overall Revenue
7.11.4. Strategic Outlook


7.12. Organogenesis
7.12.1. Business Overview
7.12.2. Product & Service Offering
7.12.3. Overall Revenue
7.12.4. Strategic Outlook

 

*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis